Event Highlights
News from Bayer
January 10, 2022
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
December 21, 2021
Not intended for U.S. and UK Media
U.S. FDA approves Xarelto™ to treat venous thromboembolism (VTE) and to prevent VTE in children
December 17, 2021
Not intended for U.S. and UK Media
Bayer receives positive CHMP opinion for finerenone as a new treatment for adult patients with chronic kidney disease associated with type 2 diabetes
Discover More Investor Resources
